Uveitis Trial, Recruiting NCT05200715 Sponsor: University of Siena Condition: Uveitis
Back to Uveitis

Uveitis Trial, Recruiting

NCT05200715
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a rare inherited inflammatory disease, confirmed by both your symptoms and a genetic test
  • You have been diagnosed with one of the following specific inflammatory conditions: Familial Mediterranean Fever, Behçet's disease, Still's disease, PFAPA syndrome, Schnitzler's disease, or CRMO (chronic recurring bone inflammation), based on recognised medical diagnostic guidelines
  • You have been diagnosed with an unclassified (undifferentiated) inflammatory disease affecting the whole body
  • You have been diagnosed with non-infectious uveitis (inflammation inside the eye that is not caused by infection), diagnosed using standard medical criteria
  • You have been diagnosed with non-infectious scleritis (inflammation of the white part of the eye, either at the front or back, that is not caused by infection)
  • You have been diagnosed with spondyloarthritis (a type of inflammatory arthritis, often affecting the spine and joints), confirmed using recognised diagnostic criteria
  • You have been diagnosed with Castleman disease (a rare condition involving abnormal growth of cells in the lymph nodes)

Who may not be able to join:

  • You, or your legal guardian or representative (if applicable), have not given your written agreement and consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393479385457

Australian sites

Flinders University, Adelaide,
University of Adelaide, Adelaide,

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Siena
Registry
ClinicalTrials.gov
Start date
6 August 2020
Est. completion
6 August 2026

Where this trial is recruiting

Algeria 🇦🇺 Australia 🇧🇪 Belgium 🇧🇷 Brazil 🇨🇳 China 🇨🇴 Colombia 🇪🇬 Egypt 🇩🇪 Germany 🇬🇷 Greece 🇮🇳 India Iran 🇮🇹 Italy Libya Martinique 🇲🇽 Mexico 🇵🇱 Poland 🇷🇴 Romania 🇸🇦 Saudi Arabia 🇪🇸 Spain Tunisia Turkey (Türkiye) 🇺🇦 Ukraine

2 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change of the number of enrolled subjects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov